The executive team at Singular Genomics has a history of working in various industries, including neuroscience and venture capitalism. They have also founded and invested in several companies, including Truvian Sciences and Aspen Neuroscience. Additionally, the team has a strong educational background, with members holding degrees from the University of California, San Diego and the Rady School of Management.
View all